MWAKIO PATTERSON - Academia.edu (original) (raw)
An author, Medical Practitioner and Anatomist. Member of Society of Maternal-Fetal Medicine (SMFM) and Journal reviewer at International journal of Gynecology and Obstetrics (IJGO).Interested in medical science and research as well as evidence based practice.
less
Uploads
Papers by MWAKIO PATTERSON
Post partum case report, 2021
Pre-eclampsia is pregnancy specific syndrome that is characterized by hypertension accompanied by... more Pre-eclampsia is pregnancy specific syndrome that is characterized by hypertension accompanied by proteinuria, developing after the 20 th week of gestation in an otherwise normotensive patient. It is a significant cause of maternal mortality and morbidity. According to WHO report of 2019, Pre-eclampsia was the 3 rd cause of mortality contributing about 14% of maternal mortality globally. This syndrome complicates about 2-5% of pregnancy, according to WHO report of 2019. The prevalence of Preeclampsia is estimated to be 10% in Africa with a mortality rate of 4 in every 1000 births in Ethiopia, Alemayehu belay et at 2016. The prevalence of pre-eclampsia in Kenya is estimated to range between 5.6 to 6.5%, but the number is expected to be higher in rural areas, Charity Ndwiga et al 2017.
Cancers is a group of diseases involving abnormal cell growth and proliferation with a potential ... more Cancers is a group of diseases involving abnormal cell growth and proliferation with a potential to invade other adjunct and distant organs. According to World Health organization (WHO) 2021 report, mortality attributable to cancers was about 10 million of people. In Africa, according to GLOBOCAN 2018, there are about 36 cancer types, there were 811, 200 new case (4.5% of the world population) and 534, 000 cancer deaths (7.3% of the total world). The annual incidence of cancers in Kenya is about 47, 887 new cases with an annual mortality of 32, 987 cases, that is, 68.8% (National cancer screening guidelines, 2nd Ed). Malignancy is the 3rd most important cause of mortality in Kenya, Infections and cardiovascular taking first and second positions respectively. To combat this big public health problem, molecular understanding of cancers is key among medical practitioners in Kenya and global at large.
Post partum case report, 2021
Pre-eclampsia is pregnancy specific syndrome that is characterized by hypertension accompanied by... more Pre-eclampsia is pregnancy specific syndrome that is characterized by hypertension accompanied by proteinuria, developing after the 20 th week of gestation in an otherwise normotensive patient. It is a significant cause of maternal mortality and morbidity. According to WHO report of 2019, Pre-eclampsia was the 3 rd cause of mortality contributing about 14% of maternal mortality globally. This syndrome complicates about 2-5% of pregnancy, according to WHO report of 2019. The prevalence of Preeclampsia is estimated to be 10% in Africa with a mortality rate of 4 in every 1000 births in Ethiopia, Alemayehu belay et at 2016. The prevalence of pre-eclampsia in Kenya is estimated to range between 5.6 to 6.5%, but the number is expected to be higher in rural areas, Charity Ndwiga et al 2017.
Cancers is a group of diseases involving abnormal cell growth and proliferation with a potential ... more Cancers is a group of diseases involving abnormal cell growth and proliferation with a potential to invade other adjunct and distant organs. According to World Health organization (WHO) 2021 report, mortality attributable to cancers was about 10 million of people. In Africa, according to GLOBOCAN 2018, there are about 36 cancer types, there were 811, 200 new case (4.5% of the world population) and 534, 000 cancer deaths (7.3% of the total world). The annual incidence of cancers in Kenya is about 47, 887 new cases with an annual mortality of 32, 987 cases, that is, 68.8% (National cancer screening guidelines, 2nd Ed). Malignancy is the 3rd most important cause of mortality in Kenya, Infections and cardiovascular taking first and second positions respectively. To combat this big public health problem, molecular understanding of cancers is key among medical practitioners in Kenya and global at large.